Azotobacter vinlandii ferritin
| Internal ID | 049f5093-d02c-4ae4-847e-ac925ed9cbd5 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | 4-[[6-amino-1-[[1-[[1-[[1-[[5-amino-1-[[1-(1H-imidazol-5-yl)-3-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[2-[[6-amino-2-[(2-amino-4-methylsulfanylbutanoyl)amino]hexanoyl]amino]acetyl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C51H89N15O13S/c1-8-29(5)42(50(78)63-36(16-17-38(55)68)46(74)59-32(26-67)22-31-24-56-27-58-31)66-49(77)41(28(3)4)64-51(79)43(30(6)9-2)65-47(75)35(15-11-13-20-53)62-48(76)37(23-40(70)71)60-39(69)25-57-45(73)34(14-10-12-19-52)61-44(72)33(54)18-21-80-7/h24,26-30,32-37,41-43H,8-23,25,52-54H2,1-7H3,(H2,55,68)(H,56,58)(H,57,73)(H,59,74)(H,60,69)(H,61,72)(H,62,76)(H,63,78)(H,64,79)(H,65,75)(H,66,77)(H,70,71) |
| InChI Key | RMHSCAZOUHDWNT-UHFFFAOYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C51H89N15O13S |
| Molecular Weight | 1152.40 g/mol |
| Exact Mass | 1151.64849913 g/mol |
| Topological Polar Surface Area (TPSA) | 491.00 Ų |
| XlogP | -4.20 |
| Atomic LogP (AlogP) | -3.03 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 15 |
| Rotatable Bonds | 42 |
| 4-((6-amino-1-((1-((1-((1-((5-amino-1-((1-(1H-imidazol-5-yl)-3-oxopropan-2-yl)amino)-1,5-dioxopentan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-1-oxohexan-2-yl)amino)-3-((2-((6-amino-2-((2-amino-4-methylsulfanylbutanoyl)amino)hexanoyl)amino)acetyl)amino)-4-oxobutanoic acid |
| 4-[[6-amino-1-[[1-[[1-[[1-[[5-amino-1-[[1-(1H-imidazol-5-yl)-3-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[2-[[6-amino-2-[(2-amino-4-methylsulfanylbutanoyl)amino]hexanoyl]amino]acetyl]amino]-4-oxobutanoic acid |
| RefChem:116150 |
| CHEBI:227299 |
| 4-[[6-amino-1-[[1-[[1-[[1-[[5-amino-1-[[1-(1H-imidazol-5-yl)-3-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-[[2-[[6-amino-2-[(2-amino-4-methylsulanylbutanoyl)amino]hexanoyl]amino]acetyl]amino]-4-oxobutanoic acid |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8288 | 82.88% |
| Caco-2 | - | 0.8644 | 86.44% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.5169 | 51.69% |
| OATP2B1 inhibitior | - | 0.8591 | 85.91% |
| OATP1B1 inhibitior | + | 0.7819 | 78.19% |
| OATP1B3 inhibitior | + | 0.9368 | 93.68% |
| MATE1 inhibitior | - | 0.9009 | 90.09% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9546 | 95.46% |
| P-glycoprotein inhibitior | + | 0.7428 | 74.28% |
| P-glycoprotein substrate | + | 0.8397 | 83.97% |
| CYP3A4 substrate | + | 0.6884 | 68.84% |
| CYP2C9 substrate | - | 0.6100 | 61.00% |
| CYP2D6 substrate | - | 0.8493 | 84.93% |
| CYP3A4 inhibition | - | 0.9667 | 96.67% |
| CYP2C9 inhibition | - | 0.8699 | 86.99% |
| CYP2C19 inhibition | - | 0.8684 | 86.84% |
| CYP2D6 inhibition | - | 0.9205 | 92.05% |
| CYP1A2 inhibition | - | 0.8731 | 87.31% |
| CYP2C8 inhibition | + | 0.7319 | 73.19% |
| CYP inhibitory promiscuity | - | 0.9907 | 99.07% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8200 | 82.00% |
| Carcinogenicity (trinary) | Non-required | 0.6419 | 64.19% |
| Eye corrosion | - | 0.9855 | 98.55% |
| Eye irritation | - | 0.8970 | 89.70% |
| Skin irritation | - | 0.7933 | 79.33% |
| Skin corrosion | - | 0.9272 | 92.72% |
| Ames mutagenesis | - | 0.6800 | 68.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6481 | 64.81% |
| Micronuclear | + | 0.5900 | 59.00% |
| Hepatotoxicity | - | 0.5698 | 56.98% |
| skin sensitisation | - | 0.8673 | 86.73% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.8250 | 82.50% |
| Nephrotoxicity | - | 0.7782 | 77.82% |
| Acute Oral Toxicity (c) | III | 0.6204 | 62.04% |
| Estrogen receptor binding | + | 0.7271 | 72.71% |
| Androgen receptor binding | + | 0.7006 | 70.06% |
| Thyroid receptor binding | + | 0.5794 | 57.94% |
| Glucocorticoid receptor binding | + | 0.6140 | 61.40% |
| Aromatase binding | + | 0.7140 | 71.40% |
| PPAR gamma | + | 0.7248 | 72.48% |
| Honey bee toxicity | - | 0.7662 | 76.62% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5700 | 57.00% |
| Fish aquatic toxicity | - | 0.5130 | 51.30% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.63% | 98.95% |
| CHEMBL4801 | P29466 | Caspase-1 | 99.33% | 96.85% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.32% | 97.23% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.61% | 96.09% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 97.48% | 90.20% |
| CHEMBL3776 | Q14790 | Caspase-8 | 97.22% | 97.06% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.77% | 99.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 96.35% | 98.94% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.14% | 98.33% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 95.91% | 89.63% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.91% | 100.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.66% | 94.45% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 95.14% | 91.38% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.12% | 93.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 94.49% | 99.35% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 94.45% | 100.00% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 94.20% | 97.21% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.96% | 96.00% |
| CHEMBL2334 | P42574 | Caspase-3 | 93.19% | 98.25% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 93.18% | 88.42% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 92.71% | 96.28% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.50% | 96.90% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 92.43% | 91.11% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 92.16% | 90.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.89% | 90.71% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 90.32% | 89.34% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.20% | 93.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.60% | 95.56% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.33% | 89.50% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 88.05% | 95.20% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 87.90% | 94.55% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 87.49% | 98.05% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 87.34% | 93.18% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 87.13% | 86.67% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 86.43% | 96.00% |
| CHEMBL3308 | P55212 | Caspase-6 | 84.85% | 97.56% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 84.64% | 95.00% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 84.60% | 97.00% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.57% | 98.75% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 84.55% | 93.03% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 83.98% | 87.45% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 83.88% | 92.29% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 83.85% | 82.69% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.59% | 100.00% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 83.44% | 95.50% |
| CHEMBL3891 | P07384 | Calpain 1 | 82.76% | 93.04% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 82.25% | 98.59% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 82.16% | 93.85% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 81.33% | 98.33% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 81.13% | 94.00% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 81.10% | 93.33% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 80.96% | 90.24% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 80.42% | 85.30% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139586731 |
| LOTUS | LTS0026648 |
| wikiData | Q105181536 |